跳至主要内容
临床试验/NCT06699030
NCT06699030招募中不适用

A New Strategy for Gallstone Expulsion Through Dietary Therapy: A Prospective, Single-Center, Double-Blind, Randomized Controlled Trial

Hepatopancreatobiliary Surgery Institute of Gansu Province1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2024年12月24日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
100
试验地点
1
主要终点
Number of patients with complete expulsion of gallbladder sludge after three days of intervention

研究概览

简要总结

This study is a double-blind, prospective, single-center controlled trial conducted at a tertiary hospital, aiming to determine whether dietary therapy can effectively expel gallstones.

详细描述

Gallstones are a common clinical condition, and their prevalence has been increasing globally in recent years. Gallstone formation is a result of various combined factors, and in its early stages, gallstones often exist in a sludge-like form. Currently, there is no definitive research on whether gallbladder sludge can be effectively expelled through medication or dietary therapy. Therefore, the investigators are conducting a double-blind, prospective, single-center controlled trial to verify whether gallbladder sludge-like stones can be effectively expelled using dietary therapy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

Double (Investigator, Participant)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Gallbladder sludge-like stones with a maximum stone diameter of less than 2 mm

排除标准

  • History of ERCP (Endoscopic Retrograde Cholangiopancreatography)
  • Previous gallstone removal surgery with gallbladder preservation
  • History of acute or chronic pancreatitis, cholangitis
  • Mirizzi Syndrome
  • History of gastrointestinal surgery
  • Gastrointestinal obstruction
  • Dysfunction of the sphincter of Oddi
  • Gallbladder neck polyps
  • Abnormal gallbladder structure
  • Gallbladder mass
  • Biliary infection or stones
  • Congenital biliary abnormalities
  • Biliary injury or surgery
  • Biliary tumors
  • Gastrointestinal bleeding, liver cirrhosis, or other malignant diseases
  • Significant arrhythmia, bradycardia, or atrioventricular block
  • Severe hypertension, liver or kidney insufficiency
  • Immune, endocrine, hematological, or mental disorders
  • Severe cerebrovascular disease
  • Allergy to relevant foods
  • Pregnant or breastfeeding women
  • Unwillingness or inability to consent to participation

研究组 & 干预措施

Functional fatty acids

Experimental

Oral Administration of functional fatty acids

干预措施: Functional fatty acids (Drug)

Placebo

Placebo Comparator

Oral Administration of Placebo

干预措施: Placebo (Other)

结局指标

主要结局

Number of patients with complete expulsion of gallbladder sludge after three days of intervention

时间窗: 7 days

Determined by ultrasound examination before and after the intervention to assess whether gallbladder sludge has been fully expelled

2)Number of patients with complete expulsion of gallbladder sludge after six days of intervention

时间窗: 7 days

Determined by ultrasound examination before and after the intervention to assess whether gallbladder sludge has been fully expelled

次要结局

  • Gallbladder Volume(7 days)
  • Gallbladder Wall Thickness(7 days)
  • Serum bilirubin(7 days)
  • Presence of Abdominal Pain Post-Intervention(7 days)
  • Occurrence of Acute Pancreatitis Post-Intervention(14 days)
  • Occurrence of Gastrointestinal Bleeding Post-Intervention(14 days)
  • Nausea, Vomiting, and Diarrhea Post-Intervention(14 days)

研究者

发起方
Hepatopancreatobiliary Surgery Institute of Gansu Province
申办方类型
Other
责任方
Principal Investigator
主要研究者

Wenbo Meng

Director of Surgery

Hepatopancreatobiliary Surgery Institute of Gansu Province

研究点 (1)

Loading locations...

相似试验